carmustine
Selected indexed studies
- Pharmacokinetics of the carmustine implant. (Clin Pharmacokinet, 2002) [PMID:12074689]
- Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. (Expert Rev Anticancer Ther, 2008) [PMID:18366283]
- Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery. (Neurochirurgie, 2017) [PMID:29122306]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pharmacokinetics of the carmustine implant. (2002) pubmed
- Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. (2008) pubmed
- Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery. (2017) pubmed
- Carmustine induces platelet apoptosis. (2015) pubmed
- The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). (1982) pubmed
- Topical carmustine (BCNU) in the treatment of mycosis fungoides. (2003) pubmed
- Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions. (2023) pubmed
- H2-antagonists and carmustine. (1989) pubmed
- Efficacy and safety of carmustine wafers in the treatment of glioblastoma multiforme: a systematic review. (2014) pubmed
- BCNU (carmustine). (1989) pubmed